ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2005

Secondary Prevention of Osteoporosis in Hip Fracture Care for Elderly Patients. Clinical and Functional Profile of Users

Belén Miguel Ibáñez, Alfonso González Ramírez, Olga Martínez González, Ana Isabel Turrión Nieves, Marta Ibáñez Martínez, Carolina Cristina Chacón Vélez, Laura Blanco Ramis, Manuel Cipriano Martín Martínez, Cristina Hidalgo Calleja, Carlos Alberto Montilla Morales, Susana Gómez Castro, Juan Francisco Blanco Blanco and Carmen Pablos Hernández, University Healthcare Complex of Salamanca, Salamanca, Spain

Meeting: ACR Convergence 2023

Keywords: Falls, Fracture, osteoporosis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1996–2018) Osteoporosis & Metabolic Bone Disease – Basic & Clinical Science Poster

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Osteoporosis is a first-rate problem in an increasingly ageing population. Falls among the elderly are a severe geriatric syndrome with relevant secondary effects. Fractures associated with both entities among the elderly are a cause of high costs and high morbidity and mortality rates. An adequate treatment of osteoporosis and fall prevention are essential factors to safeguard their well-being. The objective of this study is to analyze the clinical characteristics and circumstances of hip fractures, as well as previous fractures and anti-osteoporotic treatments in 239 elderly patients who were admitted with hip fractures in the year 2022 in the Department of Geriatric Care and Traumatology.

Methods: A descriptive, retrospective, observational and longitudinal study was conducted by analyzing the geriatric indexes, and demographic and clinical characteristics of 239 patients aged 66-99 years old who presented with low-impact hip fracture in 2022. The data analysis was carried out with SPSS.

Results: The average age of the patients was 86.79 years, with a range of 66-99 years and a predominance of women (180). During admission, a comprehensive geriatric evaluation of the situation prior to the fracture was completed. At a functional level (Table 1), the Barthel Index revealed that 182 patients had slight dependency in their daily life activities. Regarding their instrumental activities, 55 patients showed a score ≥5 out of 8. After their hip fracture, 229 patients received physical therapy in hospital and 108 patients required social interventions for their subsequent recovery. All the hip fractures were the consequence of low-impact trauma. 168 patients had suffered falls over the last year. However, according to the Downton scale, all of them (239) presented at least one risk factor for falls. These factors are detailed in Table 2. Prior to their hip fracture, 110 patients had suffered a previous low-impact fracture. The most common location was the lower limbs (46). Table 2 shows the different types of fractures. More than one previous fracture was found in 14 cases. None of the patients with previous fractures were being monitored by the Rheumatology Department. Only 22 out of the 110 patients with previous fractures were receiving or had received antiresorptive or bone-forming therapy with bisphosphonates (16), denosumab (3), denosumab after bisphosphonates (2) or teriparatide after bisphosphonates (1). All the patients received anti-osteoporotic treatment as secondary prevention upon discharge, together with denosumab (165), bisphosphonates (66) or teriparatide (8), after ruling out the scenarios included in Table 1 which could advise against their use.

Conclusion: Osteoporosis is an underdiagnosed and undertreated condition. Previous fractures often go untreated, which leads to new fractures that compromise the patients’ independence and quality of life. Hip fractures show the highest rates of morbidity and mortality. Falls play a major role in fractures among the elderly population. Their primary prevention and an adequate osteoporotic treatment must be a priority in elderly care.

Supporting image 1

Supporting image 2


Disclosures: B. Miguel Ibáñez: None; A. González Ramírez: None; O. Martínez González: None; A. Turrión Nieves: None; M. Ibáñez Martínez: None; C. Chacón Vélez: None; L. Blanco Ramis: None; M. Martín Martínez: None; C. Hidalgo Calleja: None; C. Montilla Morales: None; S. Gómez Castro: None; J. Blanco Blanco: None; C. Pablos Hernández: None.

To cite this abstract in AMA style:

Miguel Ibáñez B, González Ramírez A, Martínez González O, Turrión Nieves A, Ibáñez Martínez M, Chacón Vélez C, Blanco Ramis L, Martín Martínez M, Hidalgo Calleja C, Montilla Morales C, Gómez Castro S, Blanco Blanco J, Pablos Hernández C. Secondary Prevention of Osteoporosis in Hip Fracture Care for Elderly Patients. Clinical and Functional Profile of Users [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/secondary-prevention-of-osteoporosis-in-hip-fracture-care-for-elderly-patients-clinical-and-functional-profile-of-users/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/secondary-prevention-of-osteoporosis-in-hip-fracture-care-for-elderly-patients-clinical-and-functional-profile-of-users/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology